Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of November 3, 2026, ELAN trades at $24.35 with a market cap of $11.52B and a P/E ratio of -55.87. ELAN moved +0.50% today. Year to date, ELAN is +6.90%; over the trailing twelve months it is +8.69%. Its 52-week range spans $8.02 to $27.98. Analyst consensus is strong buy with an average price target of $30.92. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ELAN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $24.35 |
| Market Cap | $11.52B |
| P/E Ratio | -55.87 |
| EPS | $-0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.98 |
| 52-Week Low | $8.02 |
| Volume | 141.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.02B |
| Net Income | $-199.00M |
| Gross Margin | 55.36% |
14 analysts cover ELAN: 0 strong buy, 12 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.92.